{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:38:37Z","timestamp":1762299517799},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1097\/md.0000000000022650","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T19:03:47Z","timestamp":1602011027000},"page":"e22650","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin"],"prefix":"10.1097","volume":"99","author":[{"given":"Akio","family":"Miyasaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"R1-20230105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12072-019-09988-7","article-title":"APASL HCV guideline of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation","volume":"13","author":"Kanda","year":"2019","journal-title":"Hepatol Int"},{"key":"R2-20230105","first-page":"292","article-title":"HBV\/HCV Coinfection and possible reactivation of HBV following DAA use","volume":"13","author":"Gish","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"R3-20230105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00705-010-0628-x","article-title":"Identification and characterization of novel hepatitis B virus subgenotype C10 in Nusa Tenggara, Indonesia","volume":"155","author":"Mulyanto","year":"2010","journal-title":"Arch Virol"},{"key":"R4-20230105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13256-015-0630-8","article-title":"Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report","volume":"9","author":"Ende","year":"2015","journal-title":"J Med Case Rep"},{"key":"R5-20230105","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/civ474","article-title":"virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir","volume":"61","author":"Collins","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R6-20230105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/hepr.12578","article-title":"Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus\/hepatitis C virus co-infection","volume":"46","author":"Takayama","year":"2016","journal-title":"Hepatol Res"},{"key":"R7-20230105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12328-016-0657-4","article-title":"A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?","volume":"9","author":"Hayashi","year":"2016","journal-title":"Clin J Gastroenterol"},{"key":"R8-20230105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2016.02.026","article-title":"Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge","volume":"78","author":"De Monte","year":"2016","journal-title":"J Clin Virol"},{"key":"R9-20230105","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/liv.13342","article-title":"HCV\/HBV coinfection: the dark side of DAAs treatment?","volume":"37","author":"Madonia","year":"2017","journal-title":"Liver Int"},{"key":"R10-20230105","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/hepr.12905","article-title":"Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C","volume":"47","author":"Sato","year":"2017","journal-title":"Hepatol Res"},{"key":"R11-20230105","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/hepr.12919","article-title":"Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: analysis of a Japanese prospective cohort","volume":"47","author":"Doi","year":"2017","journal-title":"Hepatol Res"},{"key":"R12-20230105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/jvh.12840","article-title":"Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy","volume":"25","author":"Tamori","year":"2018","journal-title":"J Viral Hepat"},{"key":"R13-20230105","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/jvh.12737","article-title":"Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C","volume":"24","author":"Kawagishi","year":"2017","journal-title":"J Viral Hepat"},{"key":"R14-20230105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/liv.13496","article-title":"Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV","volume":"38","author":"Ogawa","year":"2018","journal-title":"Liver Int"},{"key":"R15-20230105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s15010-006-5099-3","article-title":"Difference of HBV genotype distribution between acute hepatitis and chronic hepatitis in Japan","volume":"34","author":"Takeda","year":"2006","journal-title":"Infection"},{"key":"R16-20230105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.24115","article-title":"Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection","volume":"87","author":"Kamitsukasa","year":"2015","journal-title":"J Med Virol"},{"key":"R17-20230105","first-page":"221","article-title":"The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viral interactions and management","volume":"28","author":"Konstantinou","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"R18-20230105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1440-1746.2001.02494.x","article-title":"Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection","volume":"16","author":"Dai","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20230105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hep.1840140111","article-title":"The significance of antibody to hepatitis C virus in patients with chronic hepatitis B","volume":"14","author":"Fong","year":"1991","journal-title":"Hepatology"},{"key":"R20-20230105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jcv.2005.10.006","article-title":"Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course","volume":"35","author":"Sagnelli","year":"2006","journal-title":"J Clin Virol"},{"key":"R21-20230105","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1478-3231.2007.01477.x","article-title":"Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus","volume":"27","author":"Coffin","year":"2007","journal-title":"Liver Int"},{"key":"R22-20230105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.12510","article-title":"Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis","volume":"23","author":"Meissner","year":"2016","journal-title":"J Viral Hepat"},{"key":"R23-20230105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.imbio.2016.11.003","article-title":"Different antiviral effects of IFN\u03b1 and IFN\u03b2 in an HBV mouse model","volume":"222","author":"Zhou","year":"2017","journal-title":"Immunobiology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T09:30:40Z","timestamp":1672911040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022650"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":23,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022650","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]}}}